View Archive »
Order a Reprint
About The Cover
The cover for issue 87 of Oncotarget features Figure 1, "The survival rate of genetically engineered mice with pancreatic ductal adenocarcinoma treated with a weekly injection of nano-albumin bound paclitaxel (NAB-paclitaxel) alone (orange line, n = 4), NAB-paclitaxel 3 hours after CYT-6091 treatment (green line, n = 4), and vehicle control (blue line, n = 3)," by Libutti, et al.
Table of Contents
MiRNAs prognostic for basal and BRCA1 breast cancer
MiRNAs prognostic for basal and BRCA1 breast cancer |
|
https://doi.org/10.18632/oncotarget.26297
Bhupinder Pal,
and Robin L. Anderson
|
| 35717-35718 |
A triple drug combination as a novel anti-glioma therapy?
A triple drug combination as a novel anti-glioma therapy? |
|
https://doi.org/10.18632/oncotarget.26279
Yiru Zhang,
Georg Karpel-Massler,
and Markus D. Siegelin
|
| 35719-35720 |
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD |
|
https://doi.org/10.18632/oncotarget.26291
Kidist Ashami,
John F. DiPersio,
and Jaebok Choi
|
| 35721-35722 |
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure |
|
https://doi.org/10.18632/oncotarget.26267
Steven K. Libutti,
Lawrence Tamarkin,
and Naris Nilubol
|
| 35723-35725 |
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma |
|
https://doi.org/10.18632/oncotarget.26284
Steven Georges,
Lidia Rodriguez Calleja,
Camille Jacques,
Melanie Lavaud,
Brice Moukengue,
Fernando Lecanda,
Thibaut Quillard,
Marta Tellez Gabriel,
Pierre-François Cartron,
Marc Baud’huin,
François Lamoureux,
Dominique Heymann,
and Benjamin Ory
|
| 35726-35741 |
Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance |
|
https://doi.org/10.18632/oncotarget.26285
Yusuke Takahashi,
Takashi Eguchi,
Koji Kameda,
Shaohua Lu,
Raj G. Vaghjiani,
Kay See Tan,
William D. Travis,
David R. Jones,
and Prasad S. Adusumilli
|
| 35742-35751 |
Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease
Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease |
|
https://doi.org/10.18632/oncotarget.26293
Belal A. Al-Husein,
Bara’ Dawah,
Saleem Bani-Hani,
Samir M. Al Bashir,
Khaled M. Al-Sawalmeh,
and Nehad M. Ayoub
|
| 35752-35761 |
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
|
https://doi.org/10.18632/oncotarget.26299
Nuha Mahmoud,
Mohamed E.M. Saeed,
Yoshikazu Sugimoto,
Sabine M. Klauck,
Henry J. Greten,
and Thomas Efferth
|
| 35762-35779 |
Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes
Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes |
|
https://doi.org/10.18632/oncotarget.23200
Bo Tu,
Jingfeng Bi,
Dan Wu,
Peng Zhao,
Lei Shi,
Yangxin Xie,
Xin Zhang,
Zhe Xu,
Suxia Liu,
Xinhua Wang,
Xiaoxi Li,
Fusheng Wang,
and Enqiang Qin
|
| 35780-35789 |
Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article
Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article |
|
https://doi.org/10.18632/oncotarget.26271
Victor I. Seledtsov,
and Galina V. Seledtsova
|
| 35790-35794 |
Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures
Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures |
|
https://doi.org/10.18632/oncotarget.26339
Bassil Dekky,
Michael Ruff,
Dominique Bonnier,
Vincent Legagneux,
and Nathalie Théret
|
| 35795-35795 |
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.26340
Gilles Pagès
|
| 35796-35796 |
